Baienfurt, Germany

Anita Reisenauer-Schaupp



 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 35(Granted Patents)


Location History:

  • Bad Wurzach, DE (2011)
  • Baienfurt, DE (2015 - 2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Anita Reisenauer-Schaupp: Innovator in Alzheimer’s Diagnostic Assays

Introduction

Anita Reisenauer-Schaupp is a notable inventor based in Baienfurt, Germany. With a focus on innovative diagnostic solutions, she has made significant contributions to the field of medical diagnostics, particularly in relation to Alzheimer's disease. Her work has resulted in three impactful patents that enhance our understanding and diagnosis of amyloidosis.

Latest Patents

Among her latest patents, Anita has developed assays utilizing antibodies directed against amyloid-β. These diagnostic assays are specifically designed for the diagnosis of amyloidosis, with a keen focus on Alzheimer's disease and its related aspects. This innovation includes the creation of monoclonal antibodies and corresponding antibody assays, which provide crucial tools for early diagnosis and research.

Career Highlights

Anita Reisenauer-Schaupp has made a name for herself at Probiodrug AG, a company known for its commitment to pioneering medical research and diagnostics. Through her expertise and the development of her patents, she plays an essential role in advancing the capabilities to diagnose complex neurodegenerative diseases.

Collaborations

Throughout her career, Anita has collaborated with key figures in her field, including Hans-Ulrich Demuth and Stephan Schilling. These partnerships highlight the collaborative spirit that is vital in the research and development of innovative medical technologies.

Conclusion

Anita Reisenauer-Schaupp's contributions in the realm of Alzheimer’s diagnostics underscore her role as a leading inventor in the medical field. Her patents not only enhance diagnostic processes but also pave the way for better understanding and treatment of amyloidosis and related diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…